Gene therapy of metastatic cancer by in vivo retroviral gene targeting
- 1 August 1995
- journal article
- Published by Springer Nature in Nature Genetics
- Vol. 10 (4) , 430-435
- https://doi.org/10.1038/ng0895-430
Abstract
We have achieved efficient transduction of tumour metastases in vivo by the vascular delivery of retroviral producer cells. Experimental liver metastases in mice were created by intrasplenic injection of tumour cells into the portal venous circulation. Following the establishment of micrometastases, delivery of retroviral producer cells by the same route with a vector containing the Escherichia coli beta-galactosidase (lacZ) gene demonstrated selective in vivo gene transfer to tumour deposits. By this approach, two retroviral producer cell lines encoding cytokines (IL-4 and IL-2) directed tumoricidal inflammatory responses to established metastases. Cytokine gene targeting inhibited metastasis formation and caused significant overall reduction in tumour burden. These results suggest a novel therapeutic approach for the treatment of disseminated cancer.Keywords
This publication has 14 references indexed in Scilit:
- Experimental and Clinical Studies of Cytokine Gene-Modified Tumor CellsHuman Gene Therapy, 1994
- Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans.Proceedings of the National Academy of Sciences, 1993
- In Vivo Gene Therapy of Hemophilia B: Sustained Partial Correction in Factor IX-Deficient DogsScience, 1993
- Regression of established macroscopic liver metastases after in situ transduction of a suicide gene.Proceedings of the National Academy of Sciences, 1993
- An Eosinophil-Dependent Mechanism for the Antitumor Effect of Interleukin-4Science, 1992
- In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain TumorsScience, 1992
- Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.The Journal of Experimental Medicine, 1990
- Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor responseCell, 1990
- Murine interleukin-4 displays potent anti-tumor activity in vivoCell, 1989
- Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges.Proceedings of the National Academy of Sciences, 1988